Form 4: Avidity Biosciences CFO MacLean Exercises Options and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Michael F. MacLean, CFO of Avidity Biosciences, executed stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On November 6, 2024, Michael F. MacLean, the Chief Financial Officer of Avidity Biosciences, engaged in transactions involving the company's stock.
- MacLean exercised stock options to acquire 65,182 shares at $8.82 per share and 13,875 shares at $6.57 per share.
- Concurrently, MacLean sold 27,262 shares at a weighted average price of $46.2188, 65,182 shares at a weighted average price of $45.3339, and 13,875 shares at a weighted average price of $45.3339.
- These transactions were executed under a pre-existing Rule 10b5-1 trading plan adopted on July 8, 2024.
- Following these transactions, MacLean directly owns 94,093 shares of common stock and holds options for 60,125 shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reflects routine transactions under a pre-arranged trading plan. There's no indication of positive or negative implications for the company's performance.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions. It's common for executives to utilize 10b5-1 plans to manage their stock holdings and avoid accusations of trading on inside information. The market will likely interpret this as a standard course of business for the CFO.
Key Dates
| Date | Description |
|---|---|
| 2023-09-11 | Vesting Commencement Date for 13,875 options |
| 2024-07-08 | Date of adoption of Rule 10b5-1 trading plan |
| 2024-11-06 | Date of transactions: option exercises and share sales |
| 2030-05-14 | Expiration date for 65,182 options |
| 2033-09-10 | Expiration date for 13,875 options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.